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Abstract: Dentate-gyral granule cells in the hippocampus plus dentate gyrus  
memory-recording/retrieving machine, unlike most other neurons in the brain, are 
continuously being generated in the adult brain with the important task of separating 
overlapping patterns of data streaming in from the outside world via the entorhinal cortex. 
This “adult neurogenesis” is driven by tools in the mature granule cell’s cilium. Here we 
report our discovery of leptin’s LepRb receptor in this cilium. In addition, we discuss how 
ciliary LepRb signaling might be involved with ciliary p75NTR and SSTR3 receptors in 
adult neurogenesis and memory formation as well as attenuation of Alzheimer’s 
neuropathology by reducing the production of its toxic amyloid-β-derived drivers. 
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This is a story about a set of extremely important receptor proteins found in the primary cilium 
protruding from each of the very special little granule cells or neurons of the dentate gyrus, which is 
part of the ancient hippocampal memory-recording machinery in the brain’s temporal lobes [1]. We are 
starting to realize now that these receptors are used to build retrievable memories and with them model 
our outside worlds. One such receptor is LepRb, the functional full-length, signaling receptor of leptin 
(from the Greek leptos meaning thin), a 16-kDa cytokine adipostat, mainly from white fat adipocytes. 
When carried across the blood-brain-barrier into the hypothalamus, leptin restrains feeding by firing 
STAT3 (signal transducer and activator of transcription 3), PI3K (phosphoinositide 3-kinase)/Akt (Ak 
thymoma kinase)/MAPK (mitogen-activated protein kinase)-ERK (extracellular signal-regulated 
kinase) pathway signals from LepRb into its hypothalamic target cells [2–4]. 
However, we now know that leptin influences many more brain-based functions. The LepRb 
receptor is expressed in the amygdala, the cerebral cortex, and the hippocampal CA1 field.  
As comprehensively reviewed by Tezapsidis et al. [5] and more recently by Irving and Harvey [6], 
evidence is mounting that leptin and the cascade of signals from LepRb may arrest Alzheimer’s 
disease (AD). Indeed convincing evidence supporting leptin-based therapy for AD has been 
summarized by Neurotez Inc. (Bridgewater, NJ, USA) [7]. However, before going further with the 
LepRb story, we must first understand the role of dentate gyrus and its ciliated granule cells in memory 
formation, the developing failure of which is the first detectable sign of on-coming AD. 
2. The Contribution of the Dentate Gyrus to Memory Formation 
During a person’s daily activities, the various sensors send streams of data to the different primary 
sensory regions of the cerebral cortex. Most of these are not retained long enough to be projected into 
the reverberating core network (i.e., the medial and lateral prefrontal cortices, the posterior cingulate 
and retrosplenial cortices, temporal lobes, and the hippocampus and the associated dentate gyrus) for 
further processing into a conscious image or “neuronal video” [8]. However, some of the data is sent to 
the hippocampal formation via the EC (entorhinal cortex) hub where the neurons in layer II process the 
converging polymodal data for transmission to the memory-encoding machinery in the hippocampal 
CA3 field and to the dentate gyral granule cells [9–16] (Figure 1).  
However, during a person’s customary daily activities, there is the problem of overlapping data 
streaming into the hippocampus and dentate gyrus. An efficient memory-recording machine that can 
fulfill the basic need of a mammal to adapt to a changing environment must be able to separately 
record even closely similar experiences without producing synaptic palimpsests. Moreover, this 
machinery must later be able to retrieve these stored component patterns or individual “chunks” and 
reassemble them into valid though usually experientially modified memories. Therefore, there must be 
a device that can distinguish overlapping input patterns to enable separate memory storage  
and retrieval. That device is the dentate gyrus and pattern separation and memory resolution is  
its job [10–13,17,18]. In other words, the dentate gyrus prevents palimpsests.  
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Figure 1. Receptors known to be in the cilium of a dentate granule cell. With the help of 
ACh (acetylcholine ) from BFCSNs (basal forebrain cholinergic septal neurons), signals 
from these receptors drive the progression of the progeny of rapidly proliferating initially 
non-ciliated TA (transit amplifying) cells from the stem cell niche in the dentate gyral SGZ 
(subgranular zone) to ciliated post-mitotic, mature cells in the overlying granule cell layer. 
There they receive data from the EC hub and separate overlapping patterns to produce 
retrievable distinct memories. The “tree-like” structures over the Type 3 and Mature GCs 
(granule cells) are dendrites. Also note that the green lines and arrows correspond to LepRb 
functions; red lines and arrows correspond to p75NTR functions; blue line represents primary 
cilium. Please note the Type 3 GC in this Figure is Immature GC. The symbols:  LepRb; 
 p75NTR  SSTR3. 
To do this, the dentate gyrus must be strikingly different from other parts of the brain with their 
terminally postmitotic neurons [19,20]. Having a permanent population of neurons continuously 
overwriting past memory circuits would not be the kind of data receiver the owner needs to distinguish 
between and remember the whats, whens and wheres of similar events. The solution to this problem 
was to have a constantly renewing pool of hyperexcitable granule cells, each produced initially with 
“virgin” processes on which to record novel input before maturing, loading up with synapses and 
finally fading into cellular crones. Adult neurogenesis is what makes the dentate gyrus such a key part 
of the memory-recording machinery [9–19]. Indeed, only the young adult-born granule cells mediate 
pattern separation, but as they age, they switch from separating fresh overlapping input patterns to 
restoring past inputs [21]. However, it should be noted that while a lack of new granule cells impedes 
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the formation of clearly defined memories and distinguishing between overlapping inputs, overloading 
granule cell networks with new granule cells overwrites and erases pre-existing memory circuits [22]. 
A lot of effort has been, and is being, spent trying to understand what drives adult neurogenesis and 
how these adult-born cells contribute to cognition from newborn stem cell daughters to neuronal crones. 
3. Granule Cells 
Adult granule cell production is maintained by a pool of stem cells, known as type 1 radial cells, 
housed in their special dentate gyral SGZ (subgranular zone) niche [9,19,23–26]. These type 1 cells 
have all the features of astrocytes [25]. From their SGZ niche, they shove their apical dendrites 
through the overlying tightly packed layer of mature granule cells and out into the molecular layer to 
monitor the activities in the neuronal neighborhood. It is likely that the stem cells and their progeny 
also form a tightly apposed, multicomponent but intercommunicating SGZ population, the activity 
within each of its subpopulations being determined by the signals from, and the density of, the contacts 
with the other subpopulations (Figure 1). 
A stem cell resists cell cycle entry to protect its “stemness”, which is the tissue’s “reserve 
currency”, an excessive expenditure of which may ultimately exhaust the supply of new granule cells. 
Its decision to start a clone-generating cycle depends on the overlying granule cells’ NMDA receptor 
activity, a measure of their overall functional adequacy [26–28]. A sub-threshold overlying activity 
will induce the stem cells to start a cycle to make enough functioning mature cells to restore the 
background activity. An activated stem cell will, on the average, produce one daughter like itself and a 
second daughter that will keep its cell cycle engine running, leave the niche to produce the first two 
type 2a TA (transit amplifying) cells, the most proliferatively active of the new clone of progenitor 
cells [19]. These cells lose their parental radial processes, but they still have stem cell and radial glial 
cell markers such as glial fibrillary acidic protein and express the Sox gene to prevent precocious 
differentiation. These cells proliferate in clusters around the radial scaffold and capillaries to get 
growth and development factors such as ADP/ATP, BDNF, and VEGF [9,15,19,23,24,29]. Indeed, this 
availability of VEGF is why neurogenesis is tightly linked to angiogenesis in the SGZ [26]. 
The type 2a TA cells generate the less proliferatively active type 2b cells, which by expressing the 
NeuroD1 gene shifts from the glial to the neuronal phenotype. These cells are also stimulated by Wnt 
3a from surrounding “professional” astrocytes to switch on their Prox1 gene to produce the specific 
dentate granule cell marker, which will continue to be needed by their mature progeny to maintain the 
correct gene expression pattern [9,15]. These type 2b cells are the first of the precursors to express 
Tis21, the product of which will cause their progeny to become terminally post-mitotic by inhibiting 
cell cycle-initiating cyclin D1 transcription [30]. This TIS21 expression also marks the switch to full 
synaptic integration and impending glutamatergic innervations. However, the first synapses formed by 
the newborns are with axons from GABAergic hilar basket cells, which are not the potent inhibitory 
response filters for the newborns as they are for the “adult” granule cells. In fact, immature granule 
cells receive excitatory, instead of inhibitory, signals from GABAergic synapses as they have NKCCl 
(Na+-K+-Cl−) transporters that hyperpolarize the cells by increasing their intracellular Cl− 
concentrations. Thus when GABA opens its target Cl channels, Cl− flows out, depolarizing and 
exciting the cell. However, when the young type 3 granule cell is maturing, it discards the NKCCl 
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transporter and thus has a low resting Cl− concentration. Therefore, when GABA opens its Cl 
channels, Cl− flows into the cell to hyperpolarize and inhibit it [31].  
“Infant mortality” in the SGZ is normally high. About 50% of the newborns may die without 
reaching the granule cell layer and, as in most such systems, the signals from the surviving fraction 
probably feed back to determine the stem cell/TA production level. However, this mortality can be 
reduced by NGF produced in the dentate gyrus from proNGF by the pro-domain removing tPA 
(plasminogen activator)-activated plasmin. This “mature”, i.e., “pro-less”, NGF forms 
p75NTR·NGF·TrkA complexes that are carried up the axon and stimulate the distant BFCSNs (basal 
forebrain cholinergic septal neurons) to make and secrete ACh that promotes newborn granule cell 
survival [32,33] (Figure 1). 
The surviving type 3 progeny of the type 2b cells are migratory neuroblasts. They move up into the 
lower third of the granule cell layer where they will stay and complete their maturation into functional 
ciliated granule cells. They must now become part of the dentate gyral ANTs (functionally integrated 
astrocyte-neuron teams) hill [34]. The incoming granule cells extend their newly formed, “clean-slate” 
dendrites through the upper granular layer and into the molecular layer and in the process cause the 
pre-existing astrocytes to reconfigure their structure to form close functional contacts with the arriving 
dendritic spines and synapses [34]. Now the new granule cells start learning about the outside world as 
they synapse with the axons from the EC hub (Figure 1). 
4. Involvement of the Granule Cell’s Primary Cilium in Adult Neurogenesis 
We have known since 1963 that mature dentate granule cells have a non-motile, ~4-μm primary 
cilium [35–40]. However, when do they get this antenna? According to Kumamoto et al. [41], the 
early type 2a TA neuroblasts do not have cilia. Indeed that would be expected because the cilium-
forming mother centriole and the cytoskeleton are otherwise occupied during rapid cell cycling and 
any pre-existing cilia are deacetylated and retracted by HDAC6 (histone deacetylase 6). They showed 
this with specifically marked retroviruses to label the proliferating progenitors and follow their 
development. Moreover, as expected, they found that the progeny of the proliferating progenitors 
started producing cilia only after they had stopped proliferating (i.e., in stage 3) and were inserting 
themselves into the mature granule cell layer and pushing their new dendrites through the layer of 
mature granule cells to meet the glutamatergic axons from the EC (Figure 1). At first sight, this means 
that preventing cilium formation should prevent migration and maturation but not TA cell 
proliferation. However, according to Amador-Arjona et al. [42] when SGZ cells were deprived of cilia 
by conditionally turning off their Ift20 (intraflagellar transport 20 gene [43]), there was a 50% drop in 
SGZ proliferative activity indicated by a declining fraction of DCX+, BrdU+, Ki67+, and PCNA+ 
cycling cells. Since only TA neuroblasts were affected, does this mean that TA cells are ciliated? Not 
necessarily, because this reduced proliferation was more likely to increase inhibitory “pressure” on the 
non-ciliated TA subpopulation from the build-up of deciliated newborns that could not leave the SGZ 
(Figure 1). Regardless of how the deciliation reduced neurogenesis, it partially impaired novelty 
recognition and the detection of the escape hole in a Barnes maze [42]. More recently, Berbari et al. [36] 
have also reported that deciliating the murine dentate gyrus and the hippocampal CA1 field by deleting 
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the IFT88 gene [43] resulted in impaired aversive learning and memory and novel object recognition. 
Thus, dentate granule cells must have cilia to do their memory recording jobs. 
5. Looking into the Dentate Granule Cell’s Cilium 
It has been known for ~10 years that the murine mature granule cell cilium houses Shh (sonic 
hedgehog) machinery [44,45] (Figure 1). Indeed Goetz et al. [46] have called the primary cilium a 
“hedgehog transduction machine”. In addition, Breunig et al. [47] and Han et al. [45] have shown that 
primary cilia regulate adult neurogenesis via Shh signaling. 
Then there is the pan-neurotrophin p75NTR receptor in the cilium which can be activated by BDNF, 
NGF, NT-3, NT4/5, TrkA, TrkB and, as we shall see later, even by the oligomeric Aβ drivers of 
Alzheimer’s neuropathology [37,38,48,49] (Figures 1 and 2). The localization of p75NTR to the dentate 
gyral granule cells’ cilia was surprising. It was widely believed that any p75NTR in the dentate gyrus must 
be in the axons of BFCNs neurons that have been lured to granule cell dendrites in the inner molecular 
layer to bind to factors such as NGF from granule cells and hilar neurons [32,50,51] (Figure 1). The 
BFCNs p75NTR would combine with TrkA and NGF (derived from proNGF by TPA-plasmin) to form the 
p75NTR·NGF·TrkA complex. As we said above, this complex stimulates the BFCNs to make and secrete 
ACh, which promotes the proliferation, survival, and maturation of newborn cells [32,33] (Figure 1). 
SSTR3 p75NTR
 
Figure 2. The ciliary localization of p75NTR and SSTR3 in the mature murine dentate 
granule cells. The identity of the localization of p75NTR with that of cilium-specific SSTR3 
establishes p75NTR’s ciliary localization. The anti-p75NTR and SSTR3 antibodies and the 
methodology used to immunostain these cells have been described in [37,38,51]. 
So one of p75NTR’s non-ciliary actions is to drive adult neurogenesis. However, what might ciliary 
p75NTR do? Proliferating (i.e., BrdU-labeled) SGZ cells seem to express p75NTR and knocking out the 
p75NTR gene reduces the proliferating cells and adult neurogenesis by 59%–79% [52–54]. However, 
the proliferatively competent TA cells do not have cilia according to Kumamoto et al. [41]. Instead, as 
we will see in the next paragraph the maturing granule cells’ migration and maturation-stimulating 
ciliary p75NTR might indirectly determine TA cell proliferation via the SGZ type 3 cell population 
density and feedback “pressure”. However, any interference with p75NTR gene expression and function 
would also impede the production by BFCNs of the proliferogenic and survival-promoting ACh (Figure 1). 
The most important function of ciliary p75NTR is suggested by the fact that it is the mature granule 
cells that have the ciliary p75NTR (Figure 2). What could these mature granule cells be doing with their 
ciliary p75NTR? A possible answer to this is suggested by the observation of Kumamoto et al. [41] that 
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post-mitotic type 3 newborn granule cells use their cilia to produce dendrites, start migrating upward 
and connect to the EC axons (Figure 1). Non-liganded signals from ciliary p75NTR complexed with 
those from TrkB T1 (truncated TrkB) could drive the outgrowth of the immature granule cell’s 
dendritogenic filopodia [55–57] (Figure 1). Another participant in arborization might be ceramide, 
which promotes ciliogenesis and process formation by preventing microtubule deacetylation and 
retraction via HDAC6 inhibition [58,59]. Ceramide is part of the ring-shaped pericentriolar 
compartment known as “the sphingosome” that is attached to the ciliary basal body where it functions 
in ciliogenesis and cell migration. Moreover, it has been appropriately shown to promote dendrite 
arborization in cultured rat embryonic hippocampal neurons [60,61]. The linkage of ceramide to ciliary 
p75NTR is indicated by the fact that NGF-activated p75NTR stimulates the ceramide-producing 
membrane-associated sphingomyelinase [62]. Thus, signaling from liganded and non-liganded ciliary 
p75NTR may indeed drive the ciliogenesis, dendritic arborization, and the exit of newborn cells from the 
SGZ into the mature granule cell layer indicated by the observations of Kumamoto et al. [41].  
In addition, the new mature granule cells may retain their ciliary p75NTR to maintain their cilia and 
modulate their dendritic arbors. 
Another receptor in the mature granule cell’s cilium is the non-proliferogenic, GPCR-coupled 
SSTR3 (somatostatin receptor 3) [37–40,63–65] (Figure 2). Unlike the other four SSTRs (i.e., SSTRs 
1, 2, 4, and 5), SSTR3 is confined to primary cilia by a specific cilium-targeting amino acid sequence 
in its third intracellular loop, i.e., the I3-CTS [63]. Therefore, it is important for what follows in the 
next section that if a cell produces something that co-localizes to a protruding ~4-μm structure along 
with SSTR3, that protruding structure is a cilium and that something must also be ciliary. 
Stanić et al. [40] have found that newborn neuroblasts do not put SSTR3 into their cilia, but the 
postmitotic mature granule cells in the granule cell layer, such as those in Figure 2, have loaded it into 
their cilia at a later stage of their development. Obviously, they put it into their cilia to do a “mature” 
job related to cognition. That job is memory encoding because without it, mice cannot recognize novel 
objects [64]. In addition, a lack of SSTR3 could be at least partially responsible for the cognitive 
deficit caused by granule cell deciliation recently reported by Berbari et al. [63]. 
Since adult-born granule cells do not have cilia until the type 3 stage [41], we will suggest below 
that a SSTR3-like delayed cilium loading may also apply to LepRb (Figure 1). 
6. The Ciliary Leptin Receptor in Adult Neurogenesis and AD 
As we said in the Introduction, there is evidence for an involvement of leptin and its functional 
LepRb receptor in memory formation and possibly reducing the core drivers of Alzheimer’s disease 
(AD), a very important possibility for our growing population of seniors. 
The common (>95%) form of AD, LOAD (i.e., late onset AD) or Sporadic AD starts its initially 
unnoticed, decades-long journey through the brain from its “Ground Zero” in the lateral EC [66].  
From there it spreads through existing neural circuitry, leaving disconnected networks, an atrophic 
hippocampus, and eventually a noticeably declining cognition in its wake [67]. 
The accumulating primary drivers of the slowly advancing pathology perhaps decades before the 
appearance of symptoms seem to be AβOs (Aβ42 peptide oligomers) [68–70] (Figure 3).  
Active neurons in healthy young brains produce physiologically functioning and non-toxic Aβ42 
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monomers via the sequential actions of BACE1 (beta-site amyloid precursor protein-cleaving enzyme 1) 
and γ-secretases that chop the Aβ42 off APP (amyloid-β precursor protein) (Figure 3). The resulting 
pieces are packaged into vesicles, transported down axons to their terminals, from which they are 
released during synaptic activity [71,72]. In the young brain, the cellular levels of the Aβ42 monomers 
and its variously processed and potentially dangerous derivatives are kept at a safe picomolar level by 
several proteases, such as neprilysin, as well as by ejection from the brain by LRP1 (low density 
lipoprotein receptor-related protein 1), the potent Aβ42 efflux driver [73]. However, with advancing 
age, declining disposal mechanisms enable the levels of Aβ1–42 peptides and their toxic derivatives and 
configurations to climb into the danger zone and start making “cocktails” of dynamically toxic AβOs, 
the TOCs (toxic oligomeric “cocktails”) in Figure 3 [68,70,74]. One of the reasons for the excessive 
buildup of the AβOs-forming Aβ42 is the loss, early in the spread of AD pathology, of the production 
of the neprilysin-promoting SST (somatostatin) by SST-producing cells in the dentate gyral hilus and 
the hippocampal CA1-CA3 fields [75,76] (Figure 3). 
Another consequence of the Aβ42 buildup is an increased expression of the p75NTR pan-neurotrophin 
receptor as demonstrated in both cultured SH-SY5Y human neuroblasts and hippocampal membranes 
from AD patients [37,38,51,77]. However, it is unlikely that the mature dentate granule cells’ ciliary 
p75NTR contributes to this rise and its consequences because we have observed that these cilia are 
significantly shortened (e.g., from 4- to 2.2-μm; p < 0.001) in 3xTg AD mice [37] (Figures 3 and 4). 
However, increased non-ciliary p75NTR in other hippocampal fields, such as CA1, and its stimulation 
by Aβ42 [48,49] combines with drops in TrkA and tPA to form a toxic p75NTR·Sortilin·proNGF 
complex instead of the normal 75NTR·NGF·TrkA complex [32,78] (Figures 1 and 3). The 
p75NTR·Sortilin·proNGF complex kills BFCSN cells and with them their adult neurogenesis-promoting 
ACh secretion [32] (Figure 3). 
Since adult neurogenesis normally drops with age in humans and rodents [13], it presumably should 
drop faster with the surging AβOs. Nevertheless, the increased mortality of newborn cells might  
feed-back and stimulate NSC and the non-ciliated TA cells (Figure 3). Moreover, there are indeed 
reports of increased proliferation in the early AD stages [79–81]. However, despite this, neurogenesis 
drops because the newborn neurons neither survive nor mature. This happens in part because of the 
action of pTAU, the other toxic and self-inducing AD driver, and in part owing to the lack of ACh due 
to the destruction of BFCSNs by the p75NTR·Sortilin·proNGF complex (Figure 3). Moreover, over 
time the drop in neurogenesis and declining mature cell population, perhaps because of excessive, 
apoptogenic ciliary p75NTR activation, reflexively activates stem and TA cell proliferation and 
consequently depletes the stem cell pool [79,81] (Figure 3). 
Aβ42 is a triply dangerous peptide. Besides forming the toxic AβOs, it is a self-inducing pathology 
“seed” and a transcription factor! Either exogenous or endogenous Aβ42 peptides can enter the nuclei 
of both astrocytes and neurons and promote their own endogenous production by activating the genes 
for the APP precursor and the BACE1 protease [82,83] (Figure 3). This increases Aβ42/AβOs secretion 
and spreading, reciprocal recruitment of the astrocyte-neuron members of the brain’s ANTs [84].  
But as we said above, AβOs are not alone. As Ittner and Götz [85] have said, Aβ42 and p-TAU form a 
toxic “pas de deux” (two-step) or, to over-paraphrase Bloom [86], Aβ42 is the AD gun and 
hyperphosphorylated TAUes are its bullets. 
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Figure 3. Some possible interactions between the dentate gyral granule cells’ ciliary 
receptors, AβOs (toxic oligomeric Aβ1–42) and toxic hyperphosphorylated TAU (Hp-TAU 
in the Figure and pTAU in the text) that together drive the spread of Alzheimer’s 
neuropathology from the EC to interconnected brain regions. As illustrated here, in the 
core of AD pathology are accumulating Aβ42 monomers that aggregate into 
configurationally dynamic toxic oligomeric “cocktails” (TOCs), which produce a cascade 
of protein kinases that generate the similarly self-inducing toxic pTAU by several ways.  
At first AC-TAU (acetylated TAU) resists hyperphosphorylation and aggregation, but the 
level of HDAC6 (histone deacetylase 6) rises in the AD brain and deacetylates TAU, 
which can then be hyperphosphorylated. One of the ways pTAU is made is by triggering 
CCE (cell cycle re-entry) of supposed terminally post-mitotic neurons that cannot enter 
prophase but still activate Cdk1-cyclin B1 mitotic kinase, eject Cdk5 from their nuclei into 
the cytoplasm, and activate the key cytoplasmic GSK-3β where they produce the toxic 
pTAU instead of initiating prophase. As explained in the text, the newborn granule cells no 
longer have the survival support of ACh and they also face the self-inducing toxic pTAU 
produced by the similarly self-inducing AβOs. The reduced neurogenesis in the slowly 
atrophying hippocampal structure signals stem cells to generate TA cells to replace lost 
cells but this is a futile effort because of the high mortality of their progeny. In addition, 
pTAU causes granule cells’ cilia to shrink, which might reduce the arborization, 
maturation, and migration-driving signaling from the p75NTR receptor. Note: pTAU is  
Hp-TAU in the figure to emphasize the hyperphosphorylation of the peptide. NSC: Neural 
stem cells. The green lines and arrows correspond to LepRb functions; red lines and arrows 
correspond to p75NTR functions; blue line represents primary cilium. The symbols:  
LepRb;  p75NTR  SSTR3.  
































































Figure 4. A ciliary example of the toxic Aβ42/pTAU “two-step” of Ittner and Götz [85].  
(A): Accumulating Aβ1–42 alone in 2x AD-transgenic mice does not affect the length of 
granule cilia. (B) and (C): But the length of granule cells’ cilia is shorter in  
3x AD-transgenic mice accumulating Aβ1–42 and expressing a human mutant Tau when 
immunostained with SSTR3 and p75NTR antibodies. It is likely, as shown in Figure 3, that 
the shortening is due to pTAU-promoted tubulin deacetylation and the resulting 
fragmentation of the microtubular axoneme by HDAC6 [58,87,88]. The experimental 
details may be found in Chakravarthy et al. [37]. 
The granule cell cilia provide an example of the toxic collaboration of the two AD drivers.  
These cilia are unaffected in 2xTg-AD mice which only accumulate Aβ42 (Figure 4), but they are 
significantly shorter in 3xTg-AD mice which accumulate Aβ42 and express human mutant Tau  
(Figure 4) [37]. A clue to the cause of this Tau-dependant shortening is the reduced tubulin acetylation 
and significantly elevated HDAC6 deacetylase in the cortices and hippocampi of human  
AD brains [87]. This cilial shortening may be due to HDAC6 deacetylating and thereby fragmenting 
the ciliary axonemal microtubules [58,87,88] (Figure 3). 
One-way AβO might induce the AD gun is to induce extrasynaptic NMDA receptors to let Ca2+ 
surge into the neurons. This activates AMPK, CAMKII and GSK-3β, which phosphorylate several Tau 
residues [69,89] (Figure 3). This reconfigures Tau to prevent it from working with kinesin motors to 
carry cargo to the axon terminus [89–91]. Instead of staying in the axon pTAU ectopically redistributes 
to the soma, dendrites, and synapses [86,92]. pTAU becomes a potent network disruptor by forming a 
complex with the Fyn tyrosine kinase. The AβOs start this by binding to the normal prion protein 
(PrPC) in the postsynaptic plasma membrane [90]. This activates Fyn, which phosphorylates Tau 
tyrosine residues and binds to pTAU. The resulting Fyn·pTAU complex then invades dendritic spines 
where it targets and phosphorylates NMDA receptors and induces them to admit a flood of Ca2+ that 
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destroys synapses and with them the postsynaptic machinery [86,92,93] (Figure 3). With this, the toxic 
pTAU is released in exosomes and spreads the neuropathology to its contacts [93]. 
However, there is another way to hyperphosphorylate Tau, which we have chosen to illustrate in 
Figure 3. Even before a person has reached the MCI (mild cognitive impairment) stage of the disease, 
AβOs have caused a large number of supposedly terminally post-mitotic neurons to overexpress 
MiRNA-26b. This RNA species downregulates the Rb (retinoblastoma) protein that is part of a cell 
cycle genes-associated complex consisting of Rb·E2F·Cdk5, which has been preventing CCE (cell 
cycle re-entry) by blocking the expression of major cell cycle proteins [94]. MiRNA-26b  
over-expression and Rb downregulation result in the dispersal of the genes-blocking complex, which 
starts a series of events leading to DNA replication. Indeed, the cell may finish replicating its 
chromosomes but it cannot initiate mitosis [94,95]. Nevertheless, it still expresses the Cdk1-cyclin B1 
mitotic kinase, which in a normal cell would be activated and promptly sent into the nucleus to trigger 
nuclear membrane breakdown and chromosome condensation. However, in a CCE neuron it stays in 
the cytoplasm, where it can access and phosphorylate Tau [95]. However, much before this, the  
MiRNA-26b-triggered dispersal of the nuclear CCE-blocking Rb·E2F·Cdk5 complex releases the 
Cdk5 kinase which enters the cytoplasm where it can also access and phosphorylate Tau and 
phosphorylate and inactivate any available Rb [94]. 
Thus, infectious AβOs have various ways to the produce their pTAU “bullets” and with them spread 
AD pathology. The messages from all of this are clear: AβOs are at the heart of AD pathology and to 
attenuate AD pathology you must stop the production of TOCs and their induction of pTAU bullets. 
7. Leptin Reduces Aβs Production 
It seems likely from experiments on AD-model transgenic mice as well as rats that leptin/LepRb 
might also be able to hit the source of the AD drivers in humans [6,96–98]. As we have seen, the 
primary drivers of AD pathology most likely are the AβOs. As shown in Figure 3, Aβ42, the non-toxic 
source of the toxic AβOs, is cut out of the APP precursor by BACE1 and γ-secretase. Leptin strikes at 
AD pathology by reducing Aβ1–42 production via a SIRT1 (histone deacetylase)-mediated reduction of 
BACE1 expression [99] (Figure 5). Moreover, besides reducing AβOs, leptin decreases the production 
of the synapse-destroying pTAU by inhibiting a principal Tau kinase, GSK-3β [96] (Figure 5).  
By reducing Aβ1–42 production, leptin also prevents the destructive surging of caspase 3 in synapses 
and thus the decline in synaptic density in the CA1 field and the associated hippocampus-related 
memory deficits [100] (Figure 5). However, what does leptin do to adult neurogenesis? Garza et al. [101] 
found that 14 days of intermittent intraperitoneal injections of leptin (1.0 mg/kg) into adult C5BL/6J 
mice significantly stimulated proliferation in the animals’ SGZs without affecting differentiation or 
survival of the newborn cells (Figure 1). Leptin also stimulated the STAT3/PI3k/Akt-mediated 
proliferation of cultured adult dentate progenitor cells. They later reported that intraperitoneal leptin 
injections into male Sprague-Dawley rats also overcame the glucocorticoid inhibition of adult 
neurogenesis possibly by stimulating BDNF expression [102]. 
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Figure 5. This figure, based on the mechanisms discussed in the text, describes how  
leptin-induced signaling by preciliary and ciliary LepRb in dentate granule cells and  
non-ciliary synaptic LepRb in hippocampal CA1 neurons might reduce the AD-induced loss of 
memory by attenuating or preventing the production of the toxic TOCs and pTAU in Figure 3. The 
green lines and arrows correspond to LepRb functions; red lines and arrows correspond to p75NTR 
functions; blue line represents primary cilium. The symbols:  LepRb;  p75NTR  SSTR3. 
Obviously, it would have been less traumatic than intraperitoneal injections to continuously and 
endogenously administer leptin. In addition, Pérez-González et al. [103] were able to do this elegantly.  
They produced a stable, elevated intracerebral level of leptin by injecting a HIV-Leptin gene-carrying 
lentiviral vector into the lateral cerebral ventricles of APP/PS1 AD-model transgenic mice. During the 
following 3 months, the implanted, virally vectored leptin gene activity had stimulated dentate gyral 
progenitor proliferation and attenuated Aβs-induced neurodegeneration. 
8. Where Do Dentate Granule Cells Put their LepRb? 
Because leptin stimulates adult neurogenesis by increasing progenitor proliferation but not 
maturation, we suspected that it might have been working through cilia, which, with their Shh 
machinery, have been shown to be involved in adult neurogenesis [42–45,47,104]. 
As comprehensively reviewed in [6], Harvey et al. have focused on leptin/LepRb’s ability to target 
activities in the hippocampal CA1 field. However, CA1 is not an adult neurogenesis site. Nevertheless, 
they cultured rat CA1 pyramidal neurons and found LepRb punctately distributed in cytoplasm, plasma 
membrane, and most importantly in synapses, but not in cilia (see Figure 6 of Shanley et al. [105]). 
Leptin stimulates transmission at CA1 synapses and induces LTP in slices of adult CA1 tissue by 
increasing AMPA receptor trafficking and synaptic strength. Garza et al. [101], on the other hand, 
focused on the murine dentate gyrus and its SGZ. They, like Shanley et al. [105], immunostained 
cultured neurons for LepRb (their Figure 4B). Here too LepRb was not ciliary. They also found the same 
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immunostainable punctuate cytoplasmic and perinuclear LepRb granules as did Shanley et al. [105]. 
Indeed, we have found the same distribution of immunostainable LepRb granules in cultured, leptin-
responsive SH-SY5Y human neuroblasts (Figure 6). As can be seen, these human neuroblasts were 
ciliated and at least some had even put p75NTR into their cilia like the mature murine dentate granule 
cells, but again LepRb was still not ciliary. [106,107] 
From these examples, it would seem that LepRb is not ciliary. However, in these cases the 
localization may have been affected by cellular age and other factors. In our hands, using the same 
C57/BL6 strain of mice from the same place (Jackson Laboratories, Bar Harbor, Me) as Garza et al. [101] 
the in vivo mature granule cells seemingly confined LepR to their cilia (Figure 7). There were no 
clusters of immunostainable granules like those that we found in the proliferating SH-SY5Y 
neuroblasts (Figure 6). As shown in Figure 7, the granule cells’ LepRb-containing “protrusions” also 
contained p75NTR, which we have proven to be confined to mature granule cell cilia [37,38].  
Even more convincing, they also contained SSTR3, which specifically binds only to cilia with its 







Figure 6. (A). An example of the immunostainable non-ciliary punctate distribution of 
LepRb in human SH-SY5Y neuroblastoma cells that is like the non-ciliary punctate LepRb 
distributions in cultured rat CA1 and cultured murine dentate granule cells [101,105].  
(B). These neuroblastoma cells do not have the cilium-specific SSTR3, but they have the 
cilium-specific ACIII (adenylyl cyclase III). Here we see that the immunostained Lep Rb 
particulates are not ciliary, i.e., are not co-localized with ACIII. It should be noted that 
Greco et al. [108] have shown, and we have confirmed (data not shown), that these 
neuroblasts are leptin responsive. C. It should also be noted that the cilia of the non-cycling 
SH-SY5Y cells in these cultures did contain p75NTR (immunostained as described  
in [37,38,51]), which would be consistent with the ability of the p75NTR-induced ceramide 
production to drive cilium formation [58–61]. The cells were cultured as described by 
Chakravarthy et al. [109] and the anti-LepRb monoclonal IgG1 antibody (Ob-R, B-3, and 
sc8391) was purchased from Santa Cruz Biotechnology Inc. (CA). Polyclonal anti-ACIII 
antibody (C-20, sc-588) was also purchased from Santa Cruz Biotechnology. 






Figure 7. LepRb is detectably localized only to the primary cilia of mature murine dentate 
granule cells along with p75NTR and SSTR3 receptors. Hemi-brains from 7–8 months-old 
female wild-type C57BL6 mice were immunostained with LepRb, p75NTR, or SSTR3 
antibody as described in Figures 2 and 6 and in [37,38,51]. Similar results were obtained 
with three 14–18 months-old female mice and one male mouse. When co-immunostained 
with LepRb monoclonal antibody and either SSTR3 or p75NTR polyclonal antibody, the 
signals from the LepRb and SSTR3 or p75NTR (data not shown) antibody merged (overlay) 
indicating ciliary co-localization. In all immunohistochemical studies, Dako fluorescent 
mounting medium containing DAPI DNA-binding nuclear stain was used and the tissue 
sections were examined with an Olympus fluorescence microscope as described in [37,38]. 
A similar demonstration of ciliary LepRB will also appear in Whitfield et al. [110]. 
How might this differently localized LepRb affect the leptin-induced signaling pathway in cultured 
and in vivo neurons? According to Garza et al. [102], the LepRb signal in the cultured granule cells 
follows the JAK2/STAT3/PI3K/Akt pathway as it does in the other cultured neurons. However, does 
this apply to the ciliary LepRb’s signal pathway, especially since the cilium is loaded with the 
proliferogenic Shh signal transduction mechanism needed for adult neurogenesis [45,47] (Figure 1)? 
How might these pathways be linked in the SGZ newborns? A clue is provided by the incompatibility 
of cell cycling and ciliation. As expected, the rapidly proliferating TA cells do not have cilia [41]. 
Instead, it is their non-proliferating, type 3 progeny that produce cilia when they start extruding 
processes and migrating upward into the mature granule cell layer. So it is likely that at this early stage 
the LepRB is still in the cell membrane, from which leptin stimulates their proliferation (Figures 1 and 4). 
Thus, when these cells are cultured they would only have the punctate distribution of pre-ciliary 
LeptRb reported by Garza et al. [101] and in the leptin-stimulable (data not shown) SH-SY5Y 
neuroblasts in Figure 6. 
This also suggests that the dentate granule cells only load LepRb into their cilia after they start 
maturing. This is similar to the later ciliary loading of SSTR3 reported by Stanić et al. [40].  
Thus ciliary LepRb may also be involved in a mature granule cell function such as memory encoding 
like SSTR3 [36,64] Figure 1. 




From the aforesaid it follows that recording information about the outside world streaming in from 
the EC hub and preventing any partially overlapping data from palimpsesting on recipient networks is 
the job of the very special, adult-born dentate granule cell (at least in mice). Such cells are equipped 
with ciliary receptor proteinsincluding leptin’s LepRb receptor, the pan-neurotrophin p75NTR receptor 
and the SSTR3 receptor. As summarized in Figure 1, it appears that newborn TA neurons may first use 
non-ciliary LepRb signaling to stimulate their proliferation. Then the TA cells’ progeny use their 
ciliary p75NTR to drive the production of CA3 field-connecting mossy axons and EC-connecting 
dendrites and migration from the SGZ to the mature dentate granule cell layer. Then as they settle in to 
their final “home”, they load SSTR3 and LepRb into their cilia to start recording memories. 
These are exciting questions for future studies. However, these are really just some possible 
functions of dentate granule cell’s cilium. There is likely to be more than the three potent 
receptor/drivers that we have been discussing. We have a long way to go to understand how the 
granule cells use their ciliary tools to drive adult neurogenesis, encode memories and attenuate  
AD-like pathology in transgenic mice. Most importantly, it is important to find out whether LepRb 
signaling is an AD therapeutic or more likely an AD preventative for humans. It is unlikely that signals 
from dispersed or ciliary LepRb can repair damage already inflicted by toxic AβO “cocktails” and  
Hp-Tau probably because this damage is irreversible (Figure 5). However, the continuous provision of 
leptin by a cerebrally implanted leptin gene did prevent further damage in AD-model transgenic mice [98]. 
In addition, it probably did so by blocking the productions of Aβ1–42, the source of the self-inducing 
toxic AβOs and Hp-Taues (Figure 5). Thus, leptin’s anti-amyloidogenic activity is the basis of 
Neurotez’s patent [7] for treating AD with leptin and its derivatives.  
Finally, if leptin really can target AβOs accumulation in humans as well as rodents, providing a 
steady supply of leptin may at least slow the progression of AD pathology in early-stage patients. 
Perhaps its effectiveness could also be increased with agents such as the CaSR (Ca2+-sensing 
receptor)-antagonizing calcilytic drug NPS 2143 or a similarly acting one that stops the oversecretion 
of endogenous Aβs from both astrocytes and neurones of the human cerebral cortex [84,106] and the 
~5-kDa ABP (Amyloid-β peptide) that selectively binds AβOs [107]. 
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